Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cell

• Publication date

  2002-09-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0092-8674(02)00940-6PMID 12297049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor

  2008cited by this paper
• Structure of the Extracellular Region of HER3 Reveals an Interdomain Tether

  2002cited by this paper
• Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

  2002cited by this paper
• Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain.

  2001cited by this paper
• The leucine-rich repeat as a protein recognition motif.

  2001cited by this paper
• Identification of a Heregulin Binding Site in HER3 Extracellular Domain*

  2001cited by this paper
• The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules

  2001cited by this paper
• Crystal Structure of Human Epidermal Growth Factor and Its Dimerization*

  2001cited by this paper
• The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities.

  2001cited by this paper
• Observation of an unexpected third receptor molecule in the crystal structure of human interferon-gamma receptor complex.

  2000cited by this paper
• Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.

  2000cited by this paper
• Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor

  2000cited by this paper
• Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

  2000cited by this paper
• Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.

  2000cited by this paper
• Crystal structure of the BMP-2–BRIA ectodomain complex

  2000cited by this paper
• The atomic structure of protein-protein recognition sites.

  1999cited by this paper
• Atomic structure of the GCSF–receptor complex showing a new cytokine–receptor recognition scheme

  1999cited by this paper
• Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor

  1999cited by this paper
• Role of the 6‐20 disulfide bridge in the structure and activity of epidermal growth factor

  1998cited by this paper
• Crystallization and preliminary X-ray crystallographic analysis of the EGF receptor ectodomain.

  1998cited by this paper
• Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.

  1998cited by this paper
• Specificity within the EGF family/ErbB receptor family signaling network

  1998cited by this paper
• Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression.

  1998cited by this paper
• [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods.

  1997cited by this paper
• Two EGF molecules contribute additively to stabilization of the EGFR dimer

  1997cited by this paper
• Crystal structure of the complex of diphtheria toxin with an extracellular fragment of its receptor.

  1997cited by this paper
• Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.

  1997cited by this paper
• High-resolution solution structure of the EGF-like domain of heregulin-alpha.

  1996cited by this paper
• Identification of Residues of the Epidermal Growth Factor Receptor Proximal to Residue 45 of Bound Epidermal Growth Factor*

  1996cited by this paper
• Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.

  1995cited by this paper
• Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor

  1995cited by this paper
• Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution.

  1994cited by this paper
• Three-dimensional nuclear magnetic resonance structures of mouse epidermal growth factor in acidic and physiological pH solutions.

  1994cited by this paper
• Structure-function relationships for the EGF/TGF-alpha family of mitogens.

  1994cited by this paper
• Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond.

  1994cited by this paper
• Protein microheterogeneity and crystal habits: the case of epidermal growth factor receptor isoforms as isolated in a multicompartment electrolyzer with isoelectric membranes.

  1994cited by this paper
• Solution structure of the epidermal growth factor‐like domain of heregulin‐alpha, a ligand for p180erbB‐4.

  1994cited by this paper
• Regulation of signal transduction and signal diversity by receptor oligomerization.

  1994cited by this paper
• Structure-Function relationships for the EGF/TGF-α family of mitogens

  1994cited by this paper
• Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

  1993cited by this paper
• A 40-kDa epidermal growth factor/transforming growth factor alpha-binding domain produced by limited proteolysis of the extracellular domain of the epidermal growth factor receptor.

  1993cited by this paper
• The solution structure of human transforming growth factor alpha.

  1993cited by this paper
• Solution structure of human type-alpha transforming growth factor determined by heteronuclear NMR spectroscopy and refined by energy minimization with restraints.

  1993cited by this paper
• Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.

  1992cited by this paper
• Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

  1992cited by this paper
• The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex.

  1990cited by this paper
• Functional analysis of the ligand binding site of EGF‐receptor utilizing chimeric chicken/human receptor molecules.

  1989cited by this paper
• A high-resolution 1H-NMR study of human transforming growth factor alpha. Structure and pH-dependent conformational interconversion.

  1989cited by this paper
• Human epidermal growth factor (EGF) receptor sequence recognized by EGF competitive monoclonal antibodies. Evidence for the localization of the EGF-binding site.

  1989cited by this paper
• Chicken epidermal growth factor (EGF) receptor: cDNA cloning, expression in mouse cells, and differential binding of EGF and transforming growth factor alpha

  1988cited by this paper
• Solution structure of murine epidermal growth factor: determination of the polypeptide backbone chain-fold by nuclear magnetic resonance and distance geometry.

  1987cited by this paper
• On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors.

  1987cited by this paper
• The solution structure of human epidermal growth factor

  1987cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper

• Mechanistic insights into triclosan-induced hepatotoxicity: A network toxicology and molecular docking approach.

  2026cites this paper
• Importance of integrin transmembrane helical interactions for antagonistic versus agonistic ligand behavior: Consequences for medical applications.

  2025cites this paper
• Crowdsourced Protein Design: Lessons From the Adaptyv EGFR Binder Competition

  2025cites this paper
• Spatial and stoichiometric in situ analysis of biomolecular oligomerization at single-protein resolution

  2025cites this paper
• Oxaloacetate stimulates phosphorylation of epidermal growth factor receptor in epithelial cells in vitro

  2025cites this paper
• EGFR activation and conformational "convergence": an emerging allosteric model from cancer mutations.

  2025cites this paper
• EGFR‐HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry—Implications for Targeted Therapy

  2025cites this paper
• Recent achievements in molecular insights, anticancer activities, and comparative structure activity relationships of thiazolidin-4-one derivatives as EGFR inhibitors (2019-present).

  2025cites this paper
• Unraveling the Osteogenic Activity and Molecular Mechanism of an Antioxidant Collagen Peptide in MC3T3-E1 Cells

  2025cites this paper
• Structure and organization of full-length epidermal growth factor receptor in extracellular vesicles by cryo-electron tomography

  2025cites this paper
• EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy

  2025cites this paper
• Targeting EGFR with thiazolidin-4-ones: Structure-guided design, synthesis, and in silico profiling for anticancer drug discovery.

  2025cites this paper
• Gold Nanoparticle-Based Artificial Antibodies as Stable Substitutes for Antibodies in the Immunoassay.

  2025cites this paper
• Targeting mutant EGFR in non-small cell lung cancer in the context of cell adaptation and resistance.

  2025cites this paper
• A Versatile, Simple, and Rapid (VSR) method for generating gene clones, diverse mutants, and short gene fragments for molecular biology applications

  2025cites this paper
• An antibody-drug conjugate targeting soluble and membrane-bound TGFα is effective against pancreatic tumors

  2025cites this paper
• Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present).

  2025cites this paper
• GLUT1 sensitizes tumor cells to EGFR-TKIs by binding with activated EGFR and regulating its downstream signaling pathways

  2025cites this paper
• Enhanced HER2 internalization by clathrin-dependent endocytosis in non-small cell lung cancer positive for HER2 mutations

  2025cites this paper
• Active regulation of the epidermal growth factor receptor by the membrane bilayer

  2025cites this paper
• Elevated expression and secretion of TGF-α contribute to Temozolomide resistance in human glioblastoma cells

  2025cites this paper
• Molecular docking and molecular dynamics simulation studies of the interaction of anti-oral cancer plant Curcuma longa derived-compounds with human epidermal growth factor receptor 2

  2024cites this paper
• Structural insights into the role and targeting of EGFRvIII.

  2024cites this paper
• Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation

  2024influential citation
• Structure and conformational variability of the HER2-trastuzumab-pertuzumab complex.

  2024cites this paper
• Structural dynamics of the active HER4 and HER2/HER4 complexes is finely tuned by different growth factors and glycosylation

  2024cites this paper
• Revealing the Potency of Growth Factors in Bovine Colostrum

  2024cites this paper
• Extracellular domain mutations of the EGF receptor differentially modulate high-affinity and low-affinity responses to EGF receptor ligands

  2024cites this paper
• Exploring the potential of small molecules of dual c-Met and VEGFR inhibitors for advances and future drug discovery in cancer therapy

  2024cites this paper
• Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer

  2024cites this paper
• Locally misfolded HER2 expressed on cancer cells is a promising target for development of cancer-specific antibodies.

  2024cites this paper
• Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics

  2024cites this paper
• Synthesis and biological evaluation of EGFR binding peptides for near-infrared photoimmunotherapy.

  2024cites this paper
• Targeting HER2 in solid tumors: Unveiling the structure and novel epitopes.

  2024cites this paper
• Identification of potent EGFR-TKD inhibitors from NPACT database through combined computational approaches

  2023cites this paper
• Structure and dynamics of the EGFR/HER2 heterodimer

  2023cites this paper
• How cells sense and integrate information from different sources.

  2023cites this paper
• Structural Insights into Protein-Ligand Interactions of Small Leucine Rich Repeat Proteoglycans with a Large Number of Binding Partners: An Overview

  2023cites this paper
• Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes.

  2023cites this paper
• Characterization of a novel recombinant calcium-binding protein from Arca subcrenata and its anti-hepatoma activities in vitro and in vivo.

  2023cites this paper
• Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding

  2023cites this paper
• Molecular dynamic simulation reveals the molecular interactions of epidermal growth factor receptor with musk xylene are involved in the carcinogenicity

  2023cites this paper
• Combination immunochemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: a systematic review and meta-analysis

  2023cites this paper
• Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations.

  2023cites this paper
• Cadmium promotes colorectal cancer metastasis through EGFR/Akt/mTOR signaling cascade and dynamics.

  2023cites this paper
• Distinct interactions stabilize EGFR dimers and higher-order oligomers in cell membranes

  2023cites this paper
• The T766M-EGFR lung cancer mutation promotes tumor growth by exploiting newfound mechanisms assembling ligand-free EGFR oligomer structures

  2023cites this paper
• Computational and in vitro targeting of HUVECs by ARA-Linker-TGFαL3 through VEGFR2

  2023cites this paper
• Integrating Network Pharmacology Approaches to Decipher the Multi-Target Pharmacological Mechanism of Microbial Biosurfactants as Novel Green Antimicrobials against Listeriosis

  2022cites this paper
• A perspective of fluorescence microscopy for cellular structural biology with EGFR as witness

  2022cites this paper
• Regulation of Signaling from the Epidermal Growth Factor Family.

  2022cites this paper
• Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity

  2022cites this paper
• Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancer

  2022cites this paper
• Critical roles for EGFR and EGFR–HER2 clusters in EGF binding of SW620 human carcinoma cells

  2022cites this paper
• Exploration and validation of Taraxacum mongolicum anti-cancer effect

  2022cites this paper
• Design, synthesis and biological evaluation of novel tumor hypoxia-activated EGFR tyrosine kinase inhibitors.

  2022cites this paper
• Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.

  2022cites this paper
• Design of protein-binding proteins from the target structure alone

  2022cites this paper
• A toolkit for recombinant production of seven human EGF family growth factors in active conformation

  2022cites this paper
• Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy.

  2022cites this paper
• Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling

  2022cites this paper
• It Takes More than Two to Tango: Complex, Hierarchal, and Membrane-Modulated Interactions in the Regulation of Receptor Tyrosine Kinases

  2022cites this paper
• Digital Commons@Becker Digital Analysis of the role of the C-terminal tail in the regulation of the Analysis of the role of the C-terminal tail in the regulation of the epidermal growth factor receptor epidermal growth factor receptor

  2022cites this paper
• Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias

  2022cites this paper
• PKG II secreted via the classical endoplasmic reticulum-Golgi apparatus secretory pathway blocks the activation of EGFR through phosporalting its threonine 406 and has an anti-tumor effect.

  2022cites this paper
• Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer

  2022cites this paper
• Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials

  2022cites this paper
• The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein

  2022cites this paper
• An effective strategy for ligand-mediated pulldown of the HER2/HER3/NRG1β heterocomplex and cryo-EM structure determination at low sample concentrations.

  2022cites this paper
• Disentangling ERBB Signaling in Breast Cancer Subtypes—A Model-Based Analysis

  2022cites this paper
• EGFR-Targeted Photodynamic Therapy

  2022cites this paper
• Structures of the HER2–HER3–NRG1β complex reveal a dynamic dimer interface

  2021cites this paper
• Elevated phosphorylation of EGFR in NSCLC due to mutations in PTPRH

  2021cites this paper
• Robust de novo design of protein binding proteins from target structural information alone

  2021cites this paper
• Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway

  2021cites this paper
• Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface

  2021cites this paper
• Rational Design of Constrained Peptides as Protein Interface Inhibitors

  2021cites this paper
• ARA-linker-TGFαL3: a novel chimera protein to target breast cancer cells

  2021cites this paper
• Allosteric activation of preformed EGF receptor dimers by a single ligand binding event

  2021cites this paper
• Regulation of EGFR activation and signaling by lipids on the PM.

  2021cites this paper
• Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET

  2021cites this paper
• Dealing with NSCLC EGFR mutation testing and treatment: a comprehensive review with an Italian real-world perspective.

  2021cites this paper
• Activation of the spinal EGFR signaling pathway in a rat model of cancer-induced bone pain with morphine tolerance.

  2021cites this paper
• In-Cell Single-Molecule Analysis of Molecular State and Reaction Kinetics Coupling.

  2021cites this paper
• Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses

  2021cites this paper
• Glioblastoma mutations impair ligand discrimination by EGFR

  2021influential citation
• Targeting the EGFR in cancer cells by fusion protein consisting of arazyme and third loop of TGF-alpha: an in silico study

  2021influential citation
• The EGF Domains of MUC4 Oncomucin Mediate HER2 Binding Affinity and Promote Pancreatic Cancer Cell Tumorigenesis

  2021cites this paper
• NeissLock provides an inducible protein anhydride for covalent targeting of endogenous proteins

  2021cites this paper
• The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy

  2021cites this paper
• Trastuzumab Blocks the Receiver Function of HER2 Leading to the Population Shifts of HER2-Containing Homodimers and Heterodimers

  2021cites this paper
• High‐sensitive clinical diagnostic method for PTPRZ1‐MET and the characteristic protein structure contributing to ligand‐independent MET activation

  2021cites this paper
• Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs

  2021cites this paper
• Defining Breast Cancer

  2021cites this paper
• The multicellular signalling network of ovarian cancer metastases

  2021cites this paper
• Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling

  2021cites this paper
• Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours.

  2020cites this paper
• Predicting the molecular mechanism of EGFR Domain II dimer binding interface by machine learning to identify potent small molecule inhibitor for treatment of cancer.

  2020cites this paper
• Discrete coiled coil rotamers form within the EGFRvIII juxtamembrane domain.

  2020cites this paper
• Comprehensive Model for Epidermal Growth Factor Receptor Ligand Binding Involving Conformational States of the Extracellular and the Kinase Domains

  2020cites this paper